Brief Article
Copyright ©2013 Baishideng Publishing Group Co.
World J Gastroenterol. Jul 28, 2013; 19(28): 4537-4544
Published online Jul 28, 2013. doi: 10.3748/wjg.v19.i28.4537
Figure 4
Figure 4 Cumulative overall survival according to treatment types. A: Cumulative survival rates at 2-, 4- and 6-mo in the surgical group or in the transarterial embolization (TAE) group were significantly higher in the supportive care group (each, P < 0.01); B: Cumulative survival rates at 2-, 4- and 6-mo were significantly higher in the intervention group such as surgery and TAE than in the supportive care group (P < 0.01).